In Alagille syndrome...
AIM TO DITCH THE ITCH

NOW 
APPROVED
for cholestatic pruritus (itch) in patients with Alagille syndrome who are 1 year of age and older
Dedicated Support, Designed Around You

MAP is a support program designed to be there for you when and where you need it. Once your doctor has sent your prescription to MAP, MAP has a dedicated team of experts who will help you understand the process of getting your medication.

MAP experts will:

  • Work with you and your health care team to figure out insurance coverage
  • Share financial support options for which you may be eligible
  • Conveniently ship your medication straight to your doorstep overnight when coverage is approved
  • Contact you with refill reminders and assist you with any steps needed before approving the refill
  • Connect you with a pharmacist for answers to any treatment-related questions you may have
Logo - Mirum Access Plus (MAP)

Enroll in the Support Program

When you sign up, MAP offers an enhanced, personalized experience that's designed to help you start and stay on therapy with education and resources—at no cost to you.

You can also sign up by texting ENROLL to 1‑833‑MAP‑4YOU (1‑833‑627‑4968) or downloading the consent form.

There's More to MAP

Briefcase Icon - Mirum Access Plus (MAP)

MAP Brochure

Get additional information about the support, services, and resources that MAP has to offer.

Download the MAP Brochure

Download Icon - Steps to Getting Medication

Steps to Getting Medication

Getting the medicine you need shouldn't be difficult or confusing. This helpful guide highlights the steps to getting LIVMARLI.

Download the Guide to Getting Started

Start and
Stay on Track

Start and Stay on Track
ItchCheck Logo

Check it. Chart it. Discuss it.

Log symptoms every day with Itch✓. Available in the Apple App Store® and as a printable journal, this tool allows you to track itch severity and more.

Apple® and the App Store® are registered trademarks of Apple Inc.

MAP=Mirum Access Plus.

Expand ISI Collapse ISI

Indication

LIVMARLI is a prescription medicine used to treat cholestatic pruritus (itch) in patients with Alagille syndrome 1 year of age and older. It is not known if LIVMARLI is safe and effective in children under 1 year of age or in adults 65 years and older.

Important Safety Information

What are the possible side effects of LIVMARLI?

LIVMARLI can cause serious side effects, including:

Changes in liver tests. Changes in certain liver tests are common in patients with Alagille syndrome but may worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your health care provider should do blood tests before starting and during treatment to check your liver function. Tell your health care provider right away if you get any signs or symptoms of liver problems, including:

  • nausea or vomiting
  • skin or the white part of the eye turns yellow
  • dark or brown urine
  • pain on the right side of the stomach (abdomen)
  • loss of appetite

Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea, stomach pain, and vomiting during treatment. Tell your health care provider right away if you have any of these symptoms more often or more severely than normal for you.

A condition called Fat Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamins A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your health care provider should do blood tests before starting and during treatment.

Other common side effects reported during treatment were bone fractures and gastrointestinal bleeding.

Tell your health care provider about all medicines that you take. LIVMARLI may affect the way some other medicines work, and some other medicines may affect the way LIVMARLI works. If you take a medicine that lowers cholesterol by binding bile acids, such as cholestyramine, colesevelam, or colestipol, take it at least 4 hours before or 4 hours after you take LIVMARLI.

These are not all of the possible side effects of LIVMARLI. Call your health care provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.